• Home
• About Us
• Login
• Register
• Archive
• Publication Ethics

Home > Issue 4 > Issue 4 (2023)

Summary

Articles

Prevalence and Mutation Analysis of Short-Chain acyl-CoA Dehydrogenase Deficiency Detected by Newborn Screening in Hefei, China by Haili Hu,Qingqing Ma,Weidong Li,Yan Wang,Wangsheng Song andYong Huang

Droplet Digital PCR (ddPCR) Does Not Enhance the Sensitivity of Detection of Cytomegalovirus (CMV) DNA in Newborn Dried Blood Spots Evaluated in the Context of Newborn Congenital CMV (cCMV) Screening by Nelmary Hernandez-Alvarado,Craig J. Bierle andMark R. Schleiss

Newborn Screening for Severe Combined Immunodeficiency: Lessons Learned from Screening and Follow-Up of the Preterm Newborn Population by Amy Gaviglio,Michael Lasarev,Ruthanne Sheller,Sikha Singh andMei Baker

Newborn Genetic Screening—Still a Role for Sanger Sequencing in the Era of NGS by Silje Hogner,Emma Lundman,Janne Strand,Mari Eknes Ytre-Arne,Trine Tangeraas andAsbjørg Stray-Pedersen

A False-Negative Newborn Screen for Tyrosinemia Type 1—Need for Re-Evaluation of Newborn Screening with Succinylacetone by Allysa M. Dijkstra,Kimber Evers-van Vliet,M. Rebecca Heiner-Fokkema,Frank A. J. A. Bodewes,Dennis K. Bos,József Zsiros,Koen J. van Aerde,Klaas Koop,Francjan J. van Spronsen andCharlotte M. A. Lubout

Cystic Fibrosis Cases Missed by Newborn Bloodspot Screening—Towards a Consistent Definition and Data Acquisition by Anne Munck,Kevin W. Southern,Jared Murphy,Karin M. de Winter-de Groot,Silvia Gartner,Bülent Karadag,Nataliya Kashirskaya,Barry Linnane,Marijke Proesmans,Dorota Sands,Olaf Sommerburg,Carlo Castellani andJürg Barben

Diagnosing X-Linked Adrenoleukodystrophy after Implementation of Newborn Screening: A Reference Laboratory Perspective by Julia Prinzi,Marzia Pasquali,Judith A. Hobert,Rachel Palmquist,Kristen N. Wong,Stephanie Francis andIrene De Biase

NBSTRN Tools to Advance Newborn Screening Research and Support Newborn Screening Stakeholders by Kee Chan,Zhanzhi Hu,Lynn W. Bush,Heidi Cope,Ingrid A. Holm,Stephen F. Kingsmore,Kevin Wilhelm,Curt Scharfe andAmy Brower

Newborn Screening with (C16 + C18:1)/C2 and C14/C3 for Carnitine Palmitoyltransferase II Deficiency throughout Japan Has Revealed C12/C0 as an Index of Higher Sensitivity and Specificity

RBD class 1 and 2 antibody epitopes elicit around 70% neutralizing capacity against SARS-CoV-2 virus following boosting with inactivated virus vaccine

Missed opportunities for vaccination at point of care and their impact on coverage and urban–rural coverage inequity in the Gambia Alieu Sowe, Fredinah Namatovu, Bai Cham, Per E. Gustafsson

Modeling COVID-19 vaccine booster-elicited antibody response and impact of infection history- Takara Nishiyama, Yuichiro Miyamatsu, Hyeongki Park, Naotoshi Nakamura, ... Yoji Nagasaki

Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients – Nicolás Ducasa, Paula Benencio, Ezequiel Mauro, Margarita Anders, ... Manuel Mendizabal

Commensal Neisseria cinerea outer membrane vesicles as a platform for the delivery of meningococcal and gonococcal antigens to the immune system - 27 Oct 2023 Stavroula Piliou, Theo A. Farman, Arianna Marini, Shathviga Manoharan, Pietro Mastroeni

Adherence to recommended vaccination policies for pre- and post-solid organ transplantation patients: A national questionnaire survey in Japan

Breakthrough COVID-19 infections and perceived vaccine effectiveness Stephen R. Neely, Feng Hao

Resilience of routine childhood immunization services in two counties in Kenya in the face of the COVID-19 pandemic- Harriet Mirieri, Carolyne Nasimiyu, Jeanette Dawa, Caroline Mburu, ... Jorim Ayugi

Impact of a hypothetical COVID-19 vaccine mandate on parental likelihood to vaccinate children: Exploring school-related concerns and vaccination decision-making- 27 Oct 2023 Joshua T. Sarafian, Stephanie A. Eucker, Michael Gillman, Amy M. DeLaroche, ... Brigitte M. Baumann

Analyzing an immunization resource website: User browsing trends- 27 Oct 2023 Daryl R. Cheng, Heinrich Reimer, David Le, Nigel W. Crawford

Assessing parental intention to vaccinate against COVID-19, influenza, and RSV in the United States in late 2023 Simon F. Haeder

Beyond the polysaccharide and glycoconjugate vaccines for Streptococcus pneumoniae: Does protein/peptide nanovaccines hold promises? Hitesh Harsukhbhai Chandpa, Amulya Kumar Panda, Chhuttan Lal Meena, Jairam Meena

The path to eradication of rubella Susan E. Reef, Joseph P. Icenogle, Stanley A. Plotkin

Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic- 27 Oct 2023 Nofar Amitai, Reut Wertheimer, Dario Prais, Keren-Or Wertheimer, Gilat Livni

Assessing the impact of chickenpox and shingles vaccination using intermittent enhanced surveillance in Queensland, Australia- Ashish C. Shrestha, Emma Field, Mohana Rajmokan, Stephen B. Lambert

A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of age- 27 Oct 2023 Shane Christensen, Salim Bouguermouh, Kumar Ilangovan, Michael W. Pride, ... William C. Gruber

Clinical trial registration: ClinicalTrials.gov identifier: NCT03579459. – Yongjin Choi, Soohyun Park, Jinwoo Lee, Youngsung Kim, ... Ashley M. Fox

Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda- 27 Oct 2023 Edward Man-Lik Choi, Ggayi Abu-Baker Mustapher, Gloria Omosa-Manyonyi, Julie Foster, ... Kerstin Luhn

Comparison of pneumococcal immunogenicity elicited by the PCV13 and PCV15 vaccines in adults 18 through 49 years of age- 27 Oct 2023 Isis Kanevsky, Naveen Surendran, Kathleen McElwee, Lanyu Lei, ... Mariano Young

Individual variation in vaccine immune response can produce bimodal distributions of protection- 27 Oct 2023 Cameron Zachreson, Ruarai Tobin, Joshua Szanyi, Camelia Walker, ... Nicholas Geard

Implementation of a vaccination clinic for adult solid organ transplant candidates: A single-center experience Zitta Barrella Harboe, Annemette Hald, Christina Ekenberg, Neval Ete Wareham, ... Susanne Dam Nielsen

Sequential heterologous immunization with COVID-19 vaccines induces broader neutralizing responses against SARS-CoV-2 variants in comparison with homologous boosters - 27 Oct 2023 Xiuli Shen, Yanling Hao, Shuhui Wang, Dan Li, ... Yiming Shao

“The problem is not lack of information”: A qualitative study of parents and school nurses’ perceptions of barriers and potential solutions for HPV vaccination in schools - 27 Oct 2023

Adenovirus-vectored PDCoV vaccines induce potent humoral and cellular immune responses in mice - 27 Oct 2023

Impact of the universal seasonal influenza vaccination policy in the province of Manitoba, Canada: A population-based, province-wide record-linkage study - 27 Oct 2023

Exploring factors that influence vaccination uptake for children with refugee backgrounds: An interpretive description study of primary healthcare providers’ perspectives - 27 Oct 2023 Larisa Cavit, Nadia A. Charania

Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial - 27 Oct 2023 Priscilla P.M. Nyambayo, Michael S. Gold, Ushma C. Mehta, Stephen Clarke, ... Tatenda Nyamandi

How to increase and maintain high immunization coverage: Vaccination Demand Resilience (VDR) framework Sachiko Ozawa, Holly B. Schuh, Tomoka Nakamura, Tatenda T. Yemeke, ... Noni E. MacDonald

Factors associated to influenza vaccination among hospital’s healthcare workers in the Autonomous Community of Madrid, Spain 2021–2022 - 27 Oct 2023 María Alejandra López-Zambrano, Covadonga Caso Pita, Marina Fernández Escribano, Isabel Mª Galán Meléndez, ... Amaya Sánchez Gómez

A multicenter study on the epidemiology of complicated parapneumonic effusion in the era of currently available pneumococcal conjugate vaccines - 27 Oct 2023 Smaragda Papachristidou, Vasiliki Lapea, Martha Charisi, Eleni Kourkouni, ... Maria Tsolia

The impact of over ten years of HPV vaccination in England: Surveillance of type-specific HPV in young sexually active females - 27 Oct 2023 Marta Checchi, David Mesher, Kavita Panwar, Anja Anderson, ... Kate Soldan

Tdap vaccine in pregnancy and immunogenicity of pertussis and pneumococcal vaccines in children: What is the impact of different immunization schedules? - 27 Oct 2023 Yossi Febriani, Thowiba Mansour, Manish Sadarangani, Marina Ulanova, ... Nicholas Brousseau

Identifying barriers to vaccination intention at walk-in vaccination facilities in deprived neighbourhoods: A cross-sectional survey - 27 Oct 2023 S. Sana, I. Merkelbach, T. Magnée, J. Kollmann, ... S. Denktaş

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Novavax COVID-19 Vaccine (NVX-CoV2373), a recombinant spike protein vaccine with Matrix-M adjuvant to prevent disease caused by SARS-CoV-2 viruses - 27 Oct 2023 Bethanie Wilkinson, Kinjal S. Patel, Katherine Smith, Robert Walker, ... Benefit-Risk Assessment of VAccines by TechnolOgy Working Group BRAVATO; (ex-V3SWG)